ARTICLE | Distillery Therapeutics
Therapeutics: CD160
March 26, 2015 7:00 AM UTC
Mouse studies suggest CD160-positive NK cells could boost immunotherapy to help treat solid tumors. In mouse models of melanoma and lymphoma, CD160 knockout or depletion of NK cells increased tumor gr...